TY - JOUR
T1 - The effect of albendazole toward anemia in children with soil-transmitted helminths infection in a remote and endemic area
AU - Sungkar, Saleha
AU - Tambunan, Fitry B.J.
AU - Gozali, Meutia N.
AU - Kusumowidagdo, Gladys
AU - Wahdini, Sri
N1 - Funding Information:
This study was supported by grants from the Directorate of Research and Public Services Universitas Indonesia (Direktorat Riset dan Pengabdian kepada Masyarakat Universitas Indonesia) 2017. The authors would like to thank the Perobatang Village chief for his continuous support during our study.
Publisher Copyright:
© 2019, Faculty of Medicine, Universitas Indonesia. All rights reserved.
PY - 2018/12
Y1 - 2018/12
N2 - Background: Soil-transmitted helminths (STH) infections lead to nutritional disorder and anemia among children. Albendazole 400 mg is used to control STH, although it has a low cure rate for Trichuris trichiura. The effectiveness of albendazole could be increased by giving a dose of 400 mg for 3 consecutive days. The aim of the study was to investigate the effectiveness of the triple-dose albendazole 400 mg course in decreasing STH and anemia prevalence. Methods: This study used an experimental comparative design conducted in July 2016 and January 2017 in Perobatang Village, Southwest Sumba, Indonesia. Children aged 1–15 years were asked to collect fecal samples to be examined using a Kato-Katz method. Hemoglobin level (Hb) was tested using a rapid test diagnostic strip. STH positive subjects were given 400 mg of albendazole for 3 days witnessed by the researchers. Six months after, the stool samples and Hb levels were re-examined (post-test). Results: From the 156 subjects examined (pretest), the prevalence of Ascaris lumbricoides, Trichuris trichiura, and hookworm were 65.4%, 55.8%, and 15.4%, respectively, and the prevalence of anemia was 71.2%. On post-test, the prevalence of A. lumbricoides, T. trichiura, and hookworm decreased to 8.3%, 12.8%, and 0%, respectively, and the prevalence of anemia decreased to 25%. There was a significant difference in the prevalence of STH infection and anemia before and after the administration of triple-dose albendazole (p=0.001). Conclusion: The triple-dose albendazole is effective in reducing the prevalence of STH and anemia in children with STH infection.
AB - Background: Soil-transmitted helminths (STH) infections lead to nutritional disorder and anemia among children. Albendazole 400 mg is used to control STH, although it has a low cure rate for Trichuris trichiura. The effectiveness of albendazole could be increased by giving a dose of 400 mg for 3 consecutive days. The aim of the study was to investigate the effectiveness of the triple-dose albendazole 400 mg course in decreasing STH and anemia prevalence. Methods: This study used an experimental comparative design conducted in July 2016 and January 2017 in Perobatang Village, Southwest Sumba, Indonesia. Children aged 1–15 years were asked to collect fecal samples to be examined using a Kato-Katz method. Hemoglobin level (Hb) was tested using a rapid test diagnostic strip. STH positive subjects were given 400 mg of albendazole for 3 days witnessed by the researchers. Six months after, the stool samples and Hb levels were re-examined (post-test). Results: From the 156 subjects examined (pretest), the prevalence of Ascaris lumbricoides, Trichuris trichiura, and hookworm were 65.4%, 55.8%, and 15.4%, respectively, and the prevalence of anemia was 71.2%. On post-test, the prevalence of A. lumbricoides, T. trichiura, and hookworm decreased to 8.3%, 12.8%, and 0%, respectively, and the prevalence of anemia decreased to 25%. There was a significant difference in the prevalence of STH infection and anemia before and after the administration of triple-dose albendazole (p=0.001). Conclusion: The triple-dose albendazole is effective in reducing the prevalence of STH and anemia in children with STH infection.
KW - Albendazole
KW - Anemia
KW - Soil-transmitted helminths
KW - Triple dose
UR - http://www.scopus.com/inward/record.url?scp=85059486764&partnerID=8YFLogxK
U2 - 10.13181/mji.v27i4.2857
DO - 10.13181/mji.v27i4.2857
M3 - Article
AN - SCOPUS:85059486764
SN - 0853-1773
VL - 27
SP - 293
EP - 298
JO - Medical Journal of Indonesia
JF - Medical Journal of Indonesia
IS - 4
ER -